Regulation & Compliance

When a trusted professional evades over $1 million in taxes, the impact goes beyond the courtroom, shaking public trust and starving community services.

A top proxy advisory firm urges shareholders to reject Alcon's bid for STAAR Surgical, empowering an activist investor's high-stakes governance fight.

Aligos Therapeutics is using strategic stock grants to lure top talent. Is this a savvy growth play or a creeping cost for shareholders? We break it down.

From electric cars to crypto custody, Jiuzi Holdings is chasing a $1B funding deal. A look at the massive risks and institutional hunger behind the pivot.

With its fourth acquisition under ZCG ownership, Unimed is consolidating the fragmented maritime health market, leveraging tech to create a dominant platform.

With over 123 million displaced, refugee camps are now de facto cities. Temporary water solutions are fueling disease, making the case for permanent fixes.

As Uxin prepares to report Q3 results, all eyes are on its ambitious superstore strategy and whether it can drive profitability in a complex market.

New AI voice agents promise to capture millions in lost revenue for med spas by working after hours. Is this the future of the aesthetic care market?

Lument Finance Trust's latest dividend boasts an attractive yield, but recent adjustments raise questions about the health of commercial real estate.

Erie Indemnity boosts its dividend by 7.1%, but a deeper look reveals a unique and legally challenged fee structure driving its profitability.

A new partnership between KBRA Analytics and Intex Solutions streamlines CMBS analysis, promising to enhance risk management in volatile economic times.

New journalism awards tackle AI's risks and Indigenous health gaps, revealing how media innovation aims to build a healthier, more equitable Canada.

A rejected $307M Danone offer and claims of poor governance fuel a bitter proxy fight at Lifeway Foods, pitting CEO against her largest shareholder—her brother.

A funding round reveals a deeper strategy to tackle the healthcare labor crisis and soaring Medicaid costs with tech, data, and a focus on human dignity.

Attorney Joe Massaro earns a top community-voted award, a testament to a 25-year legacy of client advocacy and trust in a competitive legal market.

Recent product recalls reveal deep flaws in our safety systems. What can this teach us about regulating the complex world of medical AI before it's too late?

From a Greenland mine to a Romanian refinery, a tech breakthrough is de-risking a vital new source of rare earths for the West's defense and green tech.

A new report finds 41% of firms have hired fraudulent candidates, exposing a critical gap between AI threats and outdated corporate defenses.

GoPro is turning user videos into a new revenue stream for the AI economy. Can this bold strategic shift save the company, or will it get lost in the ethical fog?

In a market tired of hype, investors are rewarding verifiable results. We explore the tech delivering hard proof, from quantum security to cancer therapies.